Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary

Brian G. Weinshenker

doi:10.1177/1352458515580402

Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary

Brian G. Weinshenker

Neurology

Research output: Contribution to journal › Short survey › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	693-694
Number of pages	2
Journal	Multiple Sclerosis
Volume	21
Issue number	6
DOIs	https://doi.org/10.1177/1352458515580402
State	Published - May 4 2015

ASJC Scopus subject areas

Clinical Neurology
Neurology

Access to Document

10.1177/1352458515580402

Cite this

@article{c969cb51351b48f6944c85666d0586f7,

title = "Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary",

author = "Weinshenker, {Brian G.}",

year = "2015",

month = may,

day = "4",

doi = "10.1177/1352458515580402",

language = "English (US)",

volume = "21",

pages = "693--694",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "6",

}

TY - JOUR

T1 - Placebo Studies should not be Undertaken in Neuromyelitis Optica

T2 - Commentary

AU - Weinshenker, Brian G.

PY - 2015/5/4

Y1 - 2015/5/4

UR - http://www.scopus.com/inward/record.url?scp=84930512687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930512687&partnerID=8YFLogxK

U2 - 10.1177/1352458515580402

DO - 10.1177/1352458515580402

M3 - Short survey

C2 - 25921043

AN - SCOPUS:84930512687

SN - 1352-4585

VL - 21

SP - 693

EP - 694

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 6

ER -

Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this